An In-Silico and In-Vitro Study of Imatinib and Naringin Combination for Inhibiting P-Glycoprotein and Delaying Drug Resistance in Chronic Myeloid Leukemia. Asian Journal of Pharmaceutics (AJP), [S. l.], v. 17, n. 2, 2023. DOI: 10.22377/ajp.v17i2.4859. Disponível em: https://www.asiapharmaceutics.info/index.php/ajp/article/view/4859. Acesso em: 15 apr. 2026.